Advertisement
Discussion| Volume 71, ISSUE 6, P409-410, December 2004

Comments on Elevated urinary 8-isoprostaglandin F2α in females with Graves’ hyperthyroidism: K.M. Kim, K.-J. Paéng, J.R. Hahm, D.R. Kim, B.C. Chung. Prostagl. Leukotr. and Essent. Fatty Acids 71 (2004) 143–147.

  • Hossein Ahmadzadehfar
    Affiliations
    Wilhelm Auerswald Atherosclerosis Research Group (ASF) Vienna, Nadlergasse 1, 1090 Vienna, Austria
    Search for articles by this author
  • Irmgard Neumann
    Affiliations
    ISOTOPIX – Institute for Nuclear Medicine, Vienna, Austria
    Search for articles by this author
  • Helmut Sinzinger
    Correspondence
    Corresponding author. Wilhelm Auerswald Atherosclerosis Research Group (ASF) Vienna, Nadlergasse 1, 1090 Vienna, Austria. Tel.: +4314082633; fax: +4314081366.
    Affiliations
    Wilhelm Auerswald Atherosclerosis Research Group (ASF) Vienna, Nadlergasse 1, 1090 Vienna, Austria

    ISOTOPIX – Institute for Nuclear Medicine, Vienna, Austria

    Unit for Atherosclerosis and Lipid Disorders, Danubian University Krems, Austria
    Search for articles by this author
Published:October 11, 2004DOI:https://doi.org/10.1016/j.plefa.2004.09.004
      Kim and coworkers reported an increase of 8-epi-PGF2α in females with hyperthyroidism [
      • Kim K.M.
      • Paeng K.-J.
      • Hahm J.R.
      • Kim D.R.
      • Chung B.C.
      Elevated urinary 8-isoprostaglandin F2 in females with Graves’ hyperthyroidism.
      ]. The values in urine in hypothyroidism were higher (6.09±6.07) vs. controls (2.50±2.81) but due to the high variation did not reach the level of significance. The authors are concluding that values in hypothyroidism are not different and discussing an oxidation injury in patients with hyperthyroidism. Looking on the distribution of values, the authors show in Figure 1 that the range of isoprostane levels in hyper- and hypothyroidism is not different. They did not provide any information on risk factors, as in particular smoking and hyperlipidemia, and drugs patients eventually were taking. They all might greatly influence isoprostane values.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kim K.M.
        • Paeng K.-J.
        • Hahm J.R.
        • Kim D.R.
        • Chung B.C.
        Elevated urinary 8-isoprostaglandin F2 in females with Graves’ hyperthyroidism.
        Prostagl. Leukotr. Essen. Fatty Acids. 2004; 71: 143-147
        • Asayama F.K.
        • Kato K.
        Oxidative muscular injury and its relevance to hyperthyroidism.
        Free Rad. Biol. Med. 1990; 8: 293-303
        • Helsel G.
        • Resch U.
        • Tatzber F.
        • Sinzinger H.
        Endogenous peroxide levels and autoantibodies to oxidized LDL in hyper- and hypothyroidism.
        Shock. 1999; 12 (Abstract): 16
        • Duntas L.H.
        • Mantzou E.
        • Koutras D.A.
        Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism.
        Thyroid. 2002; 12: 1003-1007
        • Diekman T.
        • Demacker P.J.
        • Kastelein J.J.
        • Stalenhoef A.F.
        • Wiersinga W.M.
        Increased oxidizability of low-density lipoproteins in hypothyroidism.
        J. Clin. Endocrinol. Metab. 1998; 83: 1752-1755
        • Resch U.
        • Helsel G.
        • Tatzber F.
        • Sinzinger H.
        Antioxidant status in thyroid dysfunction.
        Clin. Chem. Lab. Med. 2002; 40: 1132-1134
        • Wolfram R.M.
        • Palumbo B.
        • Chehne F.
        • Palumbo R.
        • Budinsky A.C.
        • Sinzinger H.
        (Iso)Prostaglandins in saliva indicate oxidation injury after radioiodine therapy.
        Rev. Esp. Med. Nucl. 2004; 23: 181-186
        • Imaizumi M.
        • Akahoshi M.
        • Ichimaru S.
        • Nakashima E.
        • Hida A.
        • Soda M.
        • Usa T.
        • Ashizawa K.
        • Yokoyama N.
        • Maeda R.
        • Nagataki S.
        • Eguchi K.
        Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism.
        J. Clin. Endocrinol. Metab. 2004; 89: 3365-3370